BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30133727)

  • 1. A New Era, New Strategies: Education and Communication Strategies to Manage Greater Access to Genomic Information.
    Lewis MA; Bonhomme N; Bloss CS
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S25-S27. PubMed ID: 30133727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Families' Experiences with Newborn Screening: A Critical Source of Evidence.
    Grob R; Roberts S; Timmermans S
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S29-S31. PubMed ID: 30133722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequencing Newborns: A Call for Nuanced Use of Genomic Technologies.
    Johnston J; Lantos JD; Goldenberg A; Chen F; Parens E; Koenig BA;
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S2-S6. PubMed ID: 30133723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Legal Dimensions of Genomic Sequencing in Newborn Screening.
    Zacharias RL; Smith ME; King JS
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S39-S41. PubMed ID: 30133728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. My Diagnostic Odyssey-A Call to Expand Access to Genomic Testing for the Next Generation.
    Michelson J
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S32-S34. PubMed ID: 30133734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Genomic Sequencing Can Offer Universal Newborn Screening Programs.
    Powell CM
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S18-S19. PubMed ID: 30133725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commercial Interests, the Technological Imperative, and Advocates: Three Forces Driving Genomic Sequencing in Newborns.
    Pereira S; Clayton EW
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S43-S44. PubMed ID: 30133724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Newborn Sequencing to Advance Understanding of the Natural History of Disease.
    Holm IA
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S45-S46. PubMed ID: 30133736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baby genome screening: paving the way to genetic discrimination?
    Seidel MG
    BMJ; 2017 Jul; 358():j3294. PubMed ID: 28729238
    [No Abstract]   [Full Text] [Related]  

  • 10. Are Parents Really Obligated to Learn as Much as Possible about Their Children's Genomes?
    Johnston J; Juengst E
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2(Suppl 2):S14-S15. PubMed ID: 30133729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic sequencing for newborn screening: current perspectives and challenges.
    Shah N; Brlek P; Bulić L; Brenner E; Škaro V; Skelin A; Projić P; Shah P; Primorac D
    Croat Med J; 2024 Jun; 65(3):261-267. PubMed ID: 38868972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eugenics Redux: "Reproductive Benefit" as a Rationale for Newborn Screening.
    Paul DB
    Hastings Cent Rep; 2018 Jul; 48 Suppl 2():S12-S13. PubMed ID: 30133732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical and Psychosocial Issues in Whole Genome Sequencing (WGS) for Newborns.
    Lantos JD
    Pediatrics; 2019 Jan; 143(Suppl 1):S1-S5. PubMed ID: 30600264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new genetics and informed consent: differentiating choice to preserve autonomy.
    Bunnik EM; de Jong A; Nijsingh N; de Wert GM
    Bioethics; 2013 Jul; 27(6):348-55. PubMed ID: 23718722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical perspective on ethical issues in genetic testing.
    Sijmons RH; Van Langen IM; Sijmons JG
    Account Res; 2011 May; 18(3):148-62. PubMed ID: 21574071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supporting Parental Decisions About Genomic Sequencing for Newborn Screening: The NC NEXUS Decision Aid.
    Lewis MA; Paquin RS; Roche MI; Furberg RD; Rini C; Berg JS; Powell CM; Bailey DB
    Pediatrics; 2016 Jan; 137 Suppl 1(Suppl 1):S16-23. PubMed ID: 26729698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequencing projects will screen 200,000 newborns for disease.
    Kaiser J
    Science; 2022 Dec; 378(6625):1159. PubMed ID: 36520905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn screening: a review of history, recent advancements, and future perspectives in the era of next generation sequencing.
    Almannai M; Marom R; Sutton VR
    Curr Opin Pediatr; 2016 Dec; 28(6):694-699. PubMed ID: 27552071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice.
    Kai J; Ulph F; Cullinan T; Qureshi N
    Health Technol Assess; 2009 Nov; 13(57):1-82, iii. PubMed ID: 19948087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.